Neoplasia/BPH

	Ejaculation sparing versus standard technique in bladder outlet obstruction procedures: a systematic review, meta-analysis, and trial sequential analysis. J Sex Med Hinojosa-Gonzalez DE, Calvillo-Ramirez A, Gutierrez-Gamez A, Saffati G, Khera M. PMID: 42770283 [PubMed - indexed for MEDLINE]
	Cabozantinib After Immunotherapy in Advanced Renal Cell Carcinoma. The CARE Study by the Hellenic Gu Cancer Group. Cancer Manag Res Bamias A, Liontos M, Binas I, Stefanou D, Tzannis K, Zakopoulou R, Dedes N, Deligiannis D, Katsiana I, Mamali A, Galari M, Kakogianni K, Nikolaidou V, Ziogas DC, Moulavasilis N, Magoula V, Giannopoulou E, Christodoulou C, Dimopoulos MA, Chrisofos M. PMID: 42770041 [PubMed]
	Nanorobots and Exosomes: Driving the New Frontier for Bladder Tumors through Non-Coding RNAs. Oncol Res Spirito L, Quintavalle C, Coppola P, Esposito M, Esposito F, De Vita G, Pallante P. PMID: 42769902 [PubMed - indexed for MEDLINE]
	Comparison of Neoadjuvant Chemotherapy, Chemoimmunotherapy, and Upfront Radical Cystectomy in High-Risk Bladder Cancer: A Single-Center Retrospective Study. Oncol Res Chen S, Gan X, Lv P, Meng Q, Lin X, Zhang Q. PMID: 42769886 [PubMed - indexed for MEDLINE]
	Bladder Cancer Biomarkers: Recent Advances in Early Detection, Treatment Prediction, and Prognosis. Oncol Res Bai Z, Song X, Sun J, Xiao W, Meng X, Dong W. PMID: 42769802 [PubMed - indexed for MEDLINE]
	Immunotherapy in Bellini Duct Carcinoma: A Systematic Review. Oncol Res Lázaro-Sánchez AD, Benítez-Fuentes JD, Wikström-Fernández S, Nevado-Rodríguez M, Conesa-Zamora P, Luengo-Gil G, Ivars-Rubio A, Zafra-Poves M, Carosella ED, Fernández-Molina B, Nieto-Olivares A, Sánchez de Las Matas Garre MJ, Arroyo AB. PMID: 42769789 [PubMed - indexed for MEDLINE]
	Programmed Cell Death in Urological Cancers: Orchestrating the Immune Microenvironment and Immunotherapy. Oncol Res Ye Z, Luo J, Zhang Y, Lu L, Lei M, Deng S. PMID: 42769782 [PubMed - indexed for MEDLINE]
	Complement tumor-crosstalk: the role of C5a receptors in urothelial carcinomas. Front Immunol Lütje LS, Gruner C, Karsten CM, Merseburger AS, Roesch MC. PMID: 42769490 [PubMed - indexed for MEDLINE]
	Changes in circulating immune cells and cytokines after high-intensity aerobic exercise in patients with prostate cancer undergoing active surveillance from the ERASE randomized controlled trial. Front Immunol Kang DW, Patel D, Field CJ, Boulé NG, Fairey AS, Schadler KL, Courneya KS. PMID: 42769245 [PubMed - indexed for MEDLINE]
	Information and Education Needs in Prostate Cancer Care in Western Guangxi, China: A Single-Center Cross-Sectional Study. J Multidiscip Healthc Cao J, He C, Ji J, Cao N, Peng X, Huang L. PMID: 42769111 [PubMed]
	Long-Term or Recurrent Antibiotic Use During Childhood or Adolescence and the Risk of Kidney Cancer: A Cohort Study. Cancer Med Liu J, Chen X, Jia L, Jing X, Pan X, Zhang X, Jing Z, Yuan J, He Q, Dai X. PMID: 42768754 [PubMed - indexed for MEDLINE]
	Impact of Photoselective Vaporization of the Prostate on Renal Function: A Pressure Flow Study-Based Analysis. Low Urin Tract Symptoms Tachikawa K, Kyoda Y, Hashimoto K, Kobayashi K, Tanaka T, Masumori N. PMID: 42767990 [PubMed - indexed for MEDLINE]
	Heterotopic prostatic tissue mimicking prostate cancer: the decisive role of multiparametric MRI. BMJ Case Rep Pedde M, Solinas E, Masala S, Scaglione M, Amadu AM. PMID: 42767790 [PubMed - indexed for MEDLINE]
	Phase 1 study of KHK2455, a long-acting, potent and selective IDO1 inhibitor, in combination with avelumab in patients with locally advanced or metastatic urothelial carcinoma. J Immunother Cancer Zakharia Y, de Spéville BD, Morales-Barrera R, Moreno I, Kilari D, Peguero J, Rao S, Shiue LH, Kanda H, Liu Y, Arora P, Vuppugalla R, Rodriguez-Vida A. PMID: 42767768 [PubMed - indexed for MEDLINE]
	Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genom Cheng N, Ouellette TW, Skead K, Singhawansa A, Elliott M, Cescon DW, Bratman SV, De Carvalho DD, Soave D, Awadalla P. PMID: 42767223 [PubMed - as supplied by publisher]
	Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial. PLoS One Merrick S, South A, Frangou E, Rush HL, Patel G, Thompson J, Plant H, Pickering L, Langley RE, Gilbert DC, Powles T, Larkin J, Meade A. PMID: 42766600 [PubMed - indexed for MEDLINE]
	Recent advances in hormone-based biopharmaceuticals for cancer therapy. J Egypt Natl Canc Inst Sarifulnazwan SN, Mohd Tajuddin NAF, Mohd Nasaruddin SNN, Muhammad Mukmin NMI, Engku Abdul Malik ESNS, Taher M, Susanti D, Khotib J, Faiyazuddin M, Widodo RT, Haris MS, Budiman H. PMID: 42766044 [PubMed - indexed for MEDLINE]
	Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy. Int J Urol Miyajima K, Yanagisawa T, Fukuokaya W, Sakakibara R, Uchida N, Miszczyk M, Inoue S, Matsukawa A, Urabe F, Mori K, Fujita N, Narita S, Hatakeyama S, Habuchi T, Shariat SF, Kimura T, JHA Collaborative Group. PMID: 42765507 [PubMed - indexed for MEDLINE]
	Task-agnostic explainable contrastive learning model for malignant cell detection in urine cytology. Biomed Phys Eng Express N P AM, Iyer RS, N PP, B JP, Dey P. PMID: 42765133 [PubMed - indexed for MEDLINE]
	Emerging Patterns of Kidney Cancer in Young Adults: Where Do We Stand? Emerging Patterns of Kidney Cancer in Young Adults: Where Do We Stand? Crit Rev Oncol Hematol Troisi P, Occhipinti D, Ligato C, Sardaro V, Campi R, Merenda E, Cappoli N, Arduini D, Messina G, Di Leo D, Neri A, Rossi F, Moosavi SK, Russo P, Foschi N, Sighinolfi C, Pierconti F, Rocco B, Tortora G, Ciccarese C, Iacovelli R. PMID: 42764100 [PubMed - as supplied by publisher]

Articles 1 - 20 / 191434

Page 1 of 9572



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy